Heather Raymon insider trades
Open-market stock purchases and sales by Heather Raymon, SVP, Research and Development at Artiva Biotherapeutics, Inc, from SEC Form 4 filings since Sep 12, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 19, 2026 | ARTV Artiva Biotherapeutics, Inc | Sold | $27.9K |
| Feb 15, 2026 | ARTV Artiva Biotherapeutics, Inc | Bought (not open market) | — |
| Feb 15, 2026 | ARTV Artiva Biotherapeutics, Inc | Sold (not open market) | $6.1K |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc | Sold (not open market) | $74.2K |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc | Sold (not open market) | $59K |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc | Sold (not open market) | $138K |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc | Bought (not open market) | — |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc | Sold (not open market) | $93.7K |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc | Sold (not open market) | $62.8K |
| Nov 15, 2025 | ARTV Artiva Biotherapeutics, Inc | Sold (not open market) | $4.5K |
Companies traded
- ARTV Artiva Biotherapeutics, Inc: 1 sale, last May 19, 2026